Category Court cases

Learning from Case Law: Case C‑456/24, AG opinion on whether or not a Supplementary Protection certificate (SPC) can be granted for an excipient

This post is an attempt to provide salient information on Case C-456/24 which concerns Halozyme Inc. vs the Supreme Administrative Court, Czech Republic. Specifically, it concerns the events leading up to the CJEU getting involved in the case as well…

Read MoreLearning from Case Law: Case C‑456/24, AG opinion on whether or not a Supplementary Protection certificate (SPC) can be granted for an excipient

European Court cases involving Supplementary Protection Certificates

Last updated: 24 December 2025 To view updates, click on the ‘+’ sign below. The table below is an attempt to present some court cases involving Supplementary Protection Certificates. You can read more about Supplementary Protection Certificates (SPCs) and Supplementary…

Read MoreEuropean Court cases involving Supplementary Protection Certificates

Learning from case law: Outcome of appeal request concerning SPC applications in the case of Halozyme Inc. vs the UK Intellectual Property Office

This is an attempt to present the facts leading to the outcome of the appeal request concerning Supplementary Protection Certificates (SPCs) in the case of Halozyme Inc. vs the UK Intellectual Property Office (IPO). The parties concerned Halozyme Inc. vs…

Read MoreLearning from case law: Outcome of appeal request concerning SPC applications in the case of Halozyme Inc. vs the UK Intellectual Property Office

Learning from Case Law: Mylan IRE Healthcare v European Commission (Case C-237/22) concerning orphan medicinal products

Last updated: 10 January 2025 To view updates, click on the ‘+’ sign below. This post is an attempt to to provide information on Case C-237/22 concerning Mylan IRE Healthcare v European Commission, including clarification of the concepts of “Significant…

Read MoreLearning from Case Law: Mylan IRE Healthcare v European Commission (Case C-237/22) concerning orphan medicinal products

Learning from Case Law: Opinion and judgement on Cases C-119/22 (MSD vs Teva) and C-149/22 (MSD vs Clonmel) on conditions under which SPCs may be granted for combination products in the EU

Last updated: 3 January 2025 To view updates, click on the ‘+’ below: This post is an attempt to to provide information on recent progress concerning two cases, one from the Finnish Market Court C-119/22 (Teva v MSD) and the…

Read MoreLearning from Case Law: Opinion and judgement on Cases C-119/22 (MSD vs Teva) and C-149/22 (MSD vs Clonmel) on conditions under which SPCs may be granted for combination products in the EU

Learning from Case Law: Preliminary ruling on Case C‑181/24 by the CJEU on the interpretation of Articles 3(b) and (d) of SPC Regulation (EC) No 469/2009

This post is an attempt to present the details of a preliminary ruling by the CJEU on Case C-181/24 (Genmab A/S vs Budapest High Court) on the interpretation of Articles 3(b) and (d) of Supplementary Protection Certificate (SPC) Regulation (EC) No 469/2009, in…

Read MoreLearning from Case Law: Preliminary ruling on Case C‑181/24 by the CJEU on the interpretation of Articles 3(b) and (d) of SPC Regulation (EC) No 469/2009

EU Supplementary Protection Certificate (SPC) manufacturing waiver put to the test in a Munich regional court (Janssen Biotech vs Formycon)

This post concerns a recent court case in which an EU Supplementary Protection Certificate manufacturing waiver was put to the test in a Munich court. About Supplementary Protection Certificate (SPC) manufacturing waivers With the entry into force of Regulation (EU) 2019/933 on…

Read MoreEU Supplementary Protection Certificate (SPC) manufacturing waiver put to the test in a Munich regional court (Janssen Biotech vs Formycon)

Learning from Case Law -Understanding the complexities associated with the affixing of proprietary trademarks to repackaged generic medicinal products, for parallel trade

Last updated: 25 July 2024 See updates at the end of the post. This post is an attempt to facilitate an understanding of some of the complexities associated with the affixing of proprietary trademarks to repackaged generic medicinal products, for…

Read MoreLearning from Case Law -Understanding the complexities associated with the affixing of proprietary trademarks to repackaged generic medicinal products, for parallel trade